These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 17611989

  • 1. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy.
    Wolfe F, Michaud K.
    J Rheumatol; 2007 Aug; 34(8):1674-83. PubMed ID: 17611989
    [Abstract] [Full Text] [Related]

  • 2. Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales.
    Wolfe F, Michaud K, Li T.
    J Rheumatol; 2006 Oct; 33(10):1942-51. PubMed ID: 16960928
    [Abstract] [Full Text] [Related]

  • 3. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.
    Heiberg MS, Nordvåg BY, Mikkelsen K, Rødevand E, Kaufmann C, Mowinckel P, Kvien TK.
    Arthritis Rheum; 2005 Aug; 52(8):2506-12. PubMed ID: 16052584
    [Abstract] [Full Text] [Related]

  • 4. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A.
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [Abstract] [Full Text] [Related]

  • 5. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response.
    Kosinski M, Kujawski SC, Martin R, Wanke LA, Buatti MC, Ware JE, Perfetto EM.
    Am J Manag Care; 2002 Mar; 8(3):231-40. PubMed ID: 11915973
    [Abstract] [Full Text] [Related]

  • 6. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy.
    Wolfe F, Michaud K.
    Am J Med; 2004 Mar 01; 116(5):305-11. PubMed ID: 14984815
    [Abstract] [Full Text] [Related]

  • 7. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
    Ernestam S, Hafström I, Werner S, Carlström K, Tengstrand B.
    J Rheumatol; 2007 Jul 01; 34(7):1451-8. PubMed ID: 17477470
    [Abstract] [Full Text] [Related]

  • 8. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients.
    Wolfe F, Michaud K.
    J Rheumatol; 2004 Nov 01; 31(11):2115-20. PubMed ID: 15517621
    [Abstract] [Full Text] [Related]

  • 9. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
    van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Ewals JA, Han KH, Hazes JM, Kerstens PJ, Peeters AJ, van Zeben D, Breedveld FC, Huizinga TW, Dijkmans BA, Allaart CF.
    Arthritis Rheum; 2009 Jan 15; 61(1):4-12. PubMed ID: 19116965
    [Abstract] [Full Text] [Related]

  • 10. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, Boesen M, Danneskiold-Samsøe B, Torp-Pedersen S.
    Scand J Rheumatol; 2006 Jan 15; 35(5):341-5. PubMed ID: 17062431
    [Abstract] [Full Text] [Related]

  • 11. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.
    Söderlin MK, Petersson IF, Geborek P.
    Scand J Rheumatol; 2012 Feb 15; 41(1):1-9. PubMed ID: 22118371
    [Abstract] [Full Text] [Related]

  • 12. Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis.
    De Filippis L, Caliri A, Anghelone S, Scibilia G, Lo Gullo R, Bagnato G.
    Panminerva Med; 2006 Jun 15; 48(2):129-35. PubMed ID: 16953150
    [Abstract] [Full Text] [Related]

  • 13. [The impact of therapy with TNF-blockers on health-related quality of life in rheumatoid arthritis patients. A pilot study].
    Abalos Medina GM, Ruiz Villaverde G, Sánchez Cano D, Ruiz Villaverde R, Ramírez Rodrigo J, Raya Álvarez E, Villaverde Gutiérrez C.
    Reumatol Clin; 2011 Jun 15; 7(3):167-71. PubMed ID: 21794808
    [Abstract] [Full Text] [Related]

  • 14. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.
    van Riel PL, Freundlich B, MacPeek D, Pedersen R, Foehl JR, Singh A, ADORE Study Investigators.
    Ann Rheum Dis; 2008 Aug 15; 67(8):1104-10. PubMed ID: 17666447
    [Abstract] [Full Text] [Related]

  • 15. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E, Wipff J, Avouac J, Kahan A, Allanore Y.
    J Rheumatol; 2009 Sep 15; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract] [Full Text] [Related]

  • 16. Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection.
    Parke FA, Reveille JD.
    Arthritis Rheum; 2004 Oct 15; 51(5):800-4. PubMed ID: 15478165
    [Abstract] [Full Text] [Related]

  • 17. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
    Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, Kim TH, Jun JB, Yoo DH, Lee JT, Bae SC.
    J Rheumatol; 2007 Apr 15; 34(4):706-11. PubMed ID: 17309133
    [Abstract] [Full Text] [Related]

  • 18. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB.
    Circulation; 2006 Sep 12; 114(11):1185-92. PubMed ID: 16952987
    [Abstract] [Full Text] [Related]

  • 19. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
    Wolfe F, Michaud K.
    Arthritis Rheum; 2007 May 12; 56(5):1433-9. PubMed ID: 17469100
    [Abstract] [Full Text] [Related]

  • 20. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
    Kaplan MJ.
    Nat Clin Pract Rheumatol; 2005 Dec 12; 1(2):74-5. PubMed ID: 16932633
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.